Panel Discussion: Progressing Ex Vivo Success into Effective In Vivo Therapies

• Applying key learnings from ex vivo developments to optimise indication selection, targeting strategies, and clinical translation for in vivo approaches
• Discussing the key scientific, regulatory considerations to streamline the integration of in vivo cell therapies into the pipeline

Speakers:

Stefanos Theoharis

Chief Executive Officer

OneChain Immunotherapeutics

Peggy Sotiropoulou

Chief Scientific Officer

T-Knife Therapeutics